Disease-Free Survival (DFS) is a clinical trial endpoint that measures the length of time after primary treatment during which a patient survives without any signs or symptoms of the disease. It is particularly important in cancer studies to evaluate the efficacy of treatments in preventing recurrence or progression of the disease.